Filing Flows › CV Sciences (CVSI) › Q2 2025
CV Sciences (CVSI) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 13, 2025
CV Sciences (CVSI) reported revenue of $3.6M for the second quarter 2025 (Q2 2025), -8% from a year earlier and +0.4% from the quarter before. Operating margin was -3.6%, net loss $261K (7.2% of revenue).
CV Sciences, Q2 2025: revenue $3.6M (-8% year over year), operating margin -3.6%, net loss $261K, operating cash flow $287K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.6M | +0.4% | -8% |
| Operating profit | −$131K | -1291% | — |
| Net earnings | −$261K | — | — |
| Operating cash flow | $287K | — | — |
| Free cash flow | $238K | — | — |
What changed
Revenue was $3.6M in Q2 2025, down 8% year over year and roughly flat from the previous quarter.
Gross margin was 50.9%, up 3.9 points from a year earlier. Operating costs exceeded revenue by $131K, an operating margin of -3.6%. Operating expenses fell 19% while revenue fell 8%. The fastest-growing cost line was Research & development (+79%). The quarter ended with a net loss of $261K, wider than the previous quarter's $109K loss.
Operating cash flow was $287K. Non-cash charges added back $58K of depreciation and amortization and $132K of share-based compensation. Working capital and other items added $358K. Capital expenditures of $49K left free cash flow of $238K.
Questions
What was CV Sciences' revenue in the second quarter 2025?
CV Sciences (CVSI) reported revenue of $3.6M for the second quarter 2025 (Q2 2025), -8% from a year earlier and +0.4% from the quarter before.
Was CV Sciences profitable in the second quarter 2025?
Operating loss was $131K (-3.6% of revenue) and net loss $261K.
Source: CV Sciences 10-Q on SEC EDGAR.